The Illinois Wellness Insider: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.

Press releases published on October 15, 2026

11 hours ago

Durable Dental Lab Expands to Buffalo Grove with New Implant-Focused Dental Center and Education Facility

Indeterminate EIN Presswire

13 hours ago

viggoVet Introduces the Intelligent Veterinary Platform, Bringing Clinical Super Intelligence into Veterinary Practice

Indeterminate EIN Presswire

4 hours ago

Paretofit Announces Founder Tobias Burkhardt's Feature in Prime Today on Sustainable Performance for Entrepreneurs

Indeterminate GlobeNewswire

4 hours ago

Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors

Indeterminate GlobeNewswire

4 hours ago

Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026

Indeterminate GlobeNewswire

5 hours ago

Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC…

Indeterminate GlobeNewswire

5 hours ago

LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026

Indeterminate GlobeNewswire

5 hours ago

Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026

Indeterminate GlobeNewswire

5 hours ago

Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026

Indeterminate GlobeNewswire

5 hours ago

Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

5 hours ago

Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference

Indeterminate GlobeNewswire

5 hours ago

Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

5 hours ago

LB Pharmaceuticals to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire

5 hours ago

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

5 hours ago

MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors

Indeterminate GlobeNewswire

5 hours ago

Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List

Indeterminate GlobeNewswire

5 hours ago

MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance

Indeterminate GlobeNewswire

5 hours ago

Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026

Indeterminate GlobeNewswire

5 hours ago

Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome

Indeterminate GlobeNewswire

6 hours ago

Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026

Indeterminate GlobeNewswire